Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2.
Brown
S
S
Bantar
C
C
Young
H K
HK
Amyes
S G
SG
D000150:Acinetobacter / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics; D000151:Acinetobacter Infections / Q000188:drug therapy*; D001426:Bacterial Proteins; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use*; D008667:Metalloproteins / Q000302:isolation & purification / Q000494:pharmacology; D010957:Plasmids; D013845:Thienamycins / Q000627:therapeutic use*; D018440:beta-Lactam Resistance; D001618:beta-Lactamases / Q000302:isolation & purification* / Q000494:pharmacology
D001426:Bacterial Proteins; D008667:Metalloproteins; D013845:Thienamycins; D015378:Imipenem; D001618:beta-Lactamases; C063912:carbapenemase